1. AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway. (1st March 2022) Authors: Liu, Chen; Huang, Yuhan; Qin, Tianyu; You, Lixin; Lu, Funian; Hu, Dianxing; Xiao, Rourou; Qin, Xu; Guo, Ensong; Yang, Bin; Li, Xi; Fan, Junpeng; Li, Xiong; Fu, Yu; Liu, Si; Wang, Zhuozi; Dou, Yingyu; Wang, Wei; Li, Wenting; Yang, Xiaohang Journal: Cancer letters Issue: Volume 528(2022) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer. Issue 21 (26th May 2022) Authors: Xiao, Rourou; You, Lixin; Zhang, Li; Guo, Xichen; Guo, Ensong; Zhao, Faming; Yang, Bin; Li, Xi; Fu, Yu; Lu, Funian; Wang, Zizhuo; Liu, Chen; Peng, Wenju; Li, Wenting; Yang, Xiaohang; Dou, Yingyu; Liu, Jingbo; Wang, Wei; Qin, Tianyu; Cui, Yaoyuan Journal: Advanced science Issue: Volume 9:Issue 21(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. It is not the time to abandon intraoperative frozen section in endometrioid adenocarcinoma: A large‐scale, multi‐center, and retrospective study. (31st January 2023) Authors: Yang, Xiaohang; Yin, Jingjing; Fu, Yu; Shen, Yuanming; Zhang, Chuyao; Yao, Shuzhong; Xu, Congjian; Xia, Min; Lou, Ge; Liu, Jihong; Lin, Bei; Wang, Jianliu; Zhao, Weidong; Zhang, Jieqing; Cheng, Wenjun; Guo, Hongyan; Guo, Ruixia; Xue, Fengxia; Wang, Xipeng; Han, Lili Journal: Cancer medicine Issue: Volume 12:Number 7(2023) Page Start: 8897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗